Tag: antivirals market analysis

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Antivirals Global Market Report 2024 Market from 2024 to 2033?

The antivirals market has experienced strong growth in recent years. It is expected to grow from $97.72 billion in 2023 to $105.73 billion in 2024, with a CAGR of 8.2%. Growth drivers include the prevalence of viral diseases, public health concerns, patent expirations, and government initiatives.

The antivirals market is projected to grow significantly, reaching $143.83 billion by 2028, with a CAGR of 8.0%. Growth is driven by emerging viral threats and global health initiatives. Key trends include technological advancements, telemedicine, and personalized medicine.

Claim Your Free Sample of the Global Antivirals Global Market Report 2024 Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What Key Factors Are Fueling the Growth of the Antivirals Global Market Report 2024 Market?

The increasing incidence of influenza is anticipated to propel the growth of the antiviral market going forward. Influenza, also called flu, is a highly contagious viral respiratory infection caused by influenza viruses that affect the nose, throat, and lungs. Antivirals are used for the treatment of influenza and are designed to inhibit the replication and spread of influenza viruses within the body. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based health agency, during 2021-2022 season, there were 9 million flu illnesses, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths. Therefore, the increasing incidence of influenza is driving the growth of the antiviral market.

What Are the Major Segments of the Antivirals Global Market Report 2024 Market?

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

What New Trends Are Transforming the Antivirals Global Market Report 2024 Market?

Companies in the anti-viral drug therapy market are advancing technologies to combat viral infections. Notably, Merck & Co. and Ridgeback Biotherapeutics launched the oral antiviral Molnupiravir in October 2021 to treat COVID-19. Approved by the FDA for emergency use, this drug is an orally administered nucleoside analog that inhibits SARS-CoV-2 replication.

Order Now for Fast Delivery of Your Antivirals Global Market Report 2024 Market Report!

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Which Regions Are Driving Growth in the Antivirals Global Market Report 2024 Market?

North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Antivirals Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the antivirals global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Antivirals Global Market Report 2024 Market Include

1. Antivirals Global Market Report 2024 Market Executive Summary

2. Antivirals Global Market Report 2024 Market Segments

3. Antivirals Global Market Report 2024 Market Size And Template Market Growth Rate

4. Key Antivirals Global Market Report 2024 Market Trends

5. Major Antivirals Global Market Report 2024 Market Drivers

……

25. Key Mergers And Acquisitions In The Antivirals Global Market Report 2024 Market

26. Top Antivirals Global Market Report 2024 Companies

27. Antivirals Global Market Report 2024 Market Opportunities And Strategies

28. Antivirals Global Market Report 2024 Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Anti-Aging Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-aging-drugs-global-market-report

Smart Pills Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

Organ-On-Chip (OOC) Opportunities And Strategies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/organ-on-chip-market#

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The antivirals market has demonstrated robust growth in recent years, signifying its pivotal role in addressing viral diseases. From $97.72 billion in 2023, the market is set to expand to $105.73 billion in 2024, showcasing a noteworthy compound annual growth rate (CAGR) of 8.2%. This surge in the historic period can be attributed to the prevalence of viral diseases, rising public health concerns, patent expirations, and various government initiatives.

Anticipating Strong Momentum Ahead
The outlook for the antivirals market remains promising, with a projected market size of $143.83 billion by 2028, underpinned by a robust CAGR of 8.0%. This anticipated growth is fueled by emerging viral threats, global health initiatives, and a continuous commitment to research and development. Notable trends in this forecast period include technological advances, the integration of telemedicine and digital health, and the rising significance of personalized medicine.

Public-Private Funding: A Catalyst for Market Expansion
The surge in public-private funding for life science research globally is poised to be a driving force for the antivirals market. The absence of approved drugs or vaccines for COVID-19 has prompted substantial investments in vaccines, treatment, and diagnostics. In June 2021, the U.S. Department of Health and Human Services, NIH, NIAID, and BARDA invested over $3 billion in the Antiviral Program for Pandemics. The Bill & Melinda Gates Foundation also contributed $120 million in October 2021 for the development and manufacture of antiviral drugs for COVID-19. This influx of funding enhances research and development, propelling the growth of the COVID-19 antivirals market.

Key Players in the Arena
Major companies shaping the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Gilead Sciences Inc., Johnson & Johnson Services Ltd., Pfizer Inc., and AstraZeneca PLC, among others. Their strategic presence underscores the competitive landscape and the market’s potential for continued growth. These industry giants contribute significantly to the development and availability of antiviral solutions.

Read More On The Antivirals Market Report 2024 – https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Innovations Driving the Market Forward
Innovation remains at the forefront of the antivirals market, with major companies focusing on groundbreaking products. PAXLOVID, an antiviral pill designed for the treatment of mild-to-moderate COVID-19, stands out as an example. Pfizer Inc. launched PAXLOVID in November 2021, gaining approval from the Food and Drug Administration. This antiviral therapy, comprising nirmatrelvir and ritonavir, effectively reduces the risk of hospitalization and death, showcasing a remarkable step forward in COVID-19 treatment.

Strategic Acquisitions: Pfizer Inc. Expands its Horizon
In a strategic move, Pfizer Inc. acquired ReViral Ltd. for $525 million in June 2022. This acquisition aims to expand Pfizer’s anti-infective pipeline, reinforcing its commitment to combat respiratory syncytial virus (RSV). ReViral Ltd., a UK-based company specializing in antiviral drugs, adds depth to Pfizer’s capabilities in developing both medicines and vaccines to address critical healthcare challenges.

Segmentation for Precision and Targeted Solutions
The antivirals market, as covered in this report, is thoughtfully segmented for a nuanced understanding:

1. By Type:
   • Branded
   • Generic
2. By Drug Class:
   • DNA Polymerase Inhibitors
   • Reverse Transcriptase Inhibitors
   • Protease Inhibitors
   • Neuraminidase Inhibitors
   • Other Drug Classes
3. By Application:
   • HIV
   • Hepatitis
   • Herpes
   • Influenza
   • Other Applications

Regional Dynamics: North America Leads, Middle East Grows Fast
In 2023, North America emerged as the largest region in the antiviral market. However, the Middle East is poised to be the fastest-growing region in the antivirals market during the forecast period, signaling the global nature of the market and its potential for widespread impact.

In Conclusion: A Dynamic Path Forward
As the antivirals market continues its upward trajectory, driven by factors like public-private funding, technological advancements, and strategic innovations, the industry stands at the forefront of addressing global health challenges. The dynamics of the market underscore the importance of collaboration, research, and innovation in shaping a future where antiviral solutions play a crucial role in safeguarding public health.

Request for A Sample Of The Global Antivirals Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=2437&type=smp